PATENT CLAIM ANALYSIS

Application Number: 16060056
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "210160"]

Abstract:
Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated modulate the NMDA receptor.

Claim (Index 9):
The compound of any one of  claims 1 - 8 , wherein R 3  is phenyl, thiophenyl, pyrimidinyl, pyrazinyl or pyridinyl, each optionally substituted by one or two substituents each independently selected from the group consisting of halogen and C 1-3 alkyl (optionally substituted by one, two or three halogens).

Metadata:
- Claim Count in Document: 8.0
- Percentile: 94.0
- Lexical Diversity: 1.48387
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13670937', '13671129', '15080351', '15506592', '12492180']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8452598322529525
- 35 USC 102 Novelty (BERT): 0.5437728882116851
- Combined Prediction Score: 0.8151111378488258
- Mean Citation Score: 391.743624
- Max Citation Score: 395.86792
- Similarity Product: 291.5422216222048

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test